Information Center
Your Health. Your Family. Your Choice.
|
|
National Vaccine Information Center Your Health. Your Family. Your Choice. |
MedAlerts Home |
| Case Details |
Administered by: Unknown Purchased by: Unknown
Life Threatening? No Write-up: Information has been received from a gynecologist concerning a 19 year old female with no previous medical history reported, who on 19-SEP-2007 was vaccinated (route and site not reported) with the 1st dose of Gardasil (Batch# NF37120, lot#1475F). On the morning of 12-OCT-2007, the patient was found dead in her bed. One week prior to death the female suffered from diarrhea, treatment without antibiotics. The patient also developed light sensitivity. The evening before the patient died she was out with a girlfriend until 3:00 am in the morning. The reporting physician excluded any drug misuse, as she knew the female as a sportive young woman. Contraception was stopped 3 months before vaccination. No reason for the death was detected in autopsy. The only finding in the autopsy was mild bronchitis and mucus. The reporting physician excluded any connection between vaccination and death. Other business partners numbers include E2007-08849(0). Additional information is not expected. | ||||||||||||||||||||
Administered by: Unknown Purchased by: Unknown
Life Threatening? No Write-up: Information has been received from a health professional concerning a 42 year old female who on 12 Apr 2008 was vaccinated with GARDASIL. Prior to the vaccination, the patient was reported looking weak and lost weight. On 14 Apr 2008, the patient returned to the clinic and complained of abdominal pain and bleeding. The patient was treated with painkillers for abdominal pain and advised to return if pain persists. The patient never came back. The second dose was due on 12 Jun 2008 but the patient did not turn up. On 14 Jun 2008, the clinic was informed that the patient had died. The cause of death was unknown. The reporter felt that abdominal pain, bleeding and death were not related to therapy with GARDASIL. No further information is available. | ||||||||||||||||||||
Administered by: Unknown Purchased by: Unknown
Life Threatening? No Write-up: Information has been received from a physician concerning a 20 year old female with no relevant medical history reported who was vaccinated with a first dose of GARDASIL on an unspecified date. Subsequently, exact onset not reported, the patient felt unwell. About 6 weeks post vaccination, she experienced pulmonary embolism with fatal outcome. An autopsy is scheduled. Other business partner numbers included: E2008-05832. Additional information has been requested. | ||||||||||||||||||||
Administered by: Unknown Purchased by: Unknown
Life Threatening? No Write-up: Information has been received from a general practitioner concerning an 18 year old female with pollen allergy, allergic asthma and who was overweight, with a family history of the mother having multiple sclerosis, who on 12-MAR-2008 was vaccinated with the first dose of GARDASIL, lot # not reported, which was well tolerated. It was reported that the second dose of GARDASIL, lot # not reported, was given intramuscularly (IM) to the right deltoid on 21-APR-2008. Concomitant therapy included SERETIDE, albuterol, NASACORT and KESTINE. There was no contraceptive use. On 16-JUL-2008 the patient experienced sudden brutal cephalgia and then she suffered from a pain evocating an aneurysm during rupture. The patient suddenly died in spite of resuscitation technique performed by the agency which evoked a ruptured aneurysm. An autopsy was on-going and the results would be provided. As to the reporter there may not be any link between adverse effect and vaccination. The reported cause of death by the ageny was ruptured cerebral aneurysm, but it had not been confirmed yet by the results of the autopsy which were still pending. Additional information has been requested. Other business partner numbers include E2008-11575. | ||||||||||||||||||||
Administered by: Unknown Purchased by: Unknown
Life Threatening? No Write-up: Information has been received from a health authority (reference # PEI2009000661) concerning a 15 year old female who on 20-OCT-2008 was vaccinated with the first dose of GARDASIL, lot #1427U (batch #NH15200) IM into the left upper arm. No information regarding toleration was given. On 29-DEC-2008, the patient was vaccinated with a second dose of GARDASIL, lot #1316U (batch #NH45640) IM into the left upper arm. On 30-DEC-2008 the patient died. According to the preliminary report, the autopsy showed no acute or chronic organic disease. The possibility of carbon monoxide intoxication was not yet ruled out. Investigation by public prosecution is ongoing. Lot checks have been requested. Other business partner numbers included: E2009-00404. Additional information has been requested. | ||||||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: This spontaneous report was received from social media, refers to unspecified number of young male patients. The patient''s medical history, concurrent conditions and concomitant medications were unknown. On an unknown date, the patients were vaccinated with GARDASIL (dose, frequency, route of administration, expiry date and lot # were not specified) for prophylaxis. On an unknown date, the patients experienced injury (majority injuries) and pain (unfathomable pain). On an unknown date, the patients died due to unknown reason. It was also reported on an unknown date that, dangerous bills were passed to mandate the suspect GARDASIL (lethal injection) and also allow the minors to receive without "Parental Consent" as prophylactic treatment to prevent STD''s (sexually transmitted diseases) in millions of boys in more than 52 countries around the world. The outcome of pain and injury was unknown. The causality assessment was not reported. This was one of the several reports. | ||||||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? Yes Write-up: This spontaneous report was received from a journalist and refers to unspecified number of female patients of unknown age (reported as young). There was no information about the patients'' concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patients were vaccinated with GARDASIL for prophylaxis (dose, route and site of administration, lot number and expiration date were not reported). On unknown dates (reported as follow vaccinations), the patients experienced life-threatening or lethal side effects. The cause o f death was not provided. The outcome of the events was unknown. The relatedness between the events and the GARDASIL was not provided. This is one of several reports received from the same reporter. Sender''s Comments: US-009507513-1905USA003023: US-009507513-1905USA003024: US-009507513-1905USA003025: US-009507513-1905USA003113. | ||||||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: patient died; tested post mortem blood samples and found fragments of foreign DNA in her spleen and these were positive for human papilloma virus; This spontaneous report has been received from a physician as a social media post referring to a female patient of unknown age.Information on patient''s medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with third dose Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) (dose, anatomical location, route, lot# and expiry date was not reported) for prophylaxis. On an unknown date, the patient died in her sleep six months after her third Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) injection due to unknown reason. On an unknown date, the autopsy (reported as post-martem blood test) was performed which showed fragments of foreign deoxyribose nucleic acid (DNA) in patient''s blood and spleen and those samples were positive for human papilloma virus (HPV) (Human papilloma virus test positive). Physician also reported that it was not the result of natural HPV infection, most likely the DNA was bound to aluminum, which was also found in the patient. The physician further mentioned that HPV gene was foreign DNA and its detection six months after the injection was not normal. The physician also tested five samples of the vaccine sent from somewhere else and found HPV vaccine in each. Causality assessment between the events and the suspect therapy was unknown.; Reported Cause(s) of Death: unknown cause of death. | ||||||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: three days after vaccination the patient died; This spontaneous report was received from a nurse practitioner via a company representative and refers to a healthy female patient of unknown age. The patient''s concurrent conditions, medical history, concomitant therapies, drug reactions and allergies were not reported. On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) or quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), (unidentified Merck hpv vaccine administered; name, dose, route of administration, lot # and expiration date were not reported) for prophylaxis. On an unknown date, reported as three days after vaccination, the patient died. The cause of death was unknown. It was unknown if an autopsy was done. The relatedness between the patient''s death and suspect vaccine was not provided. | ||||||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? Yes Write-up: The patient developed a fever, was hospitalized at an unspecified hospital for an unspecified length of time; The patient "eventually died" on an unspecified date several years ago. Cause of death: unknown; This spontaneous report was received from the pharmacist via a company representative, referring to a 16-year-old female patient. The patient''s current conditions, medical history, concomitant medications, drug reactions or allergies were not reported. On an unknown date (reported as "several years ago"), the patient received unidentified Merck hpv vaccine administered (name and lot for prophylaxis (dose, strength, lot# and expiration date were not reported) or HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) as prophylaxis (dose, strength, lot# and expiration date were not reported). The patient was vaccinated at the clinic of an unspecified physician, not at a pharmacy. On an unspecified date (reported as "several years ago"), the patient developed a fever, was hospitalized at an unspecified hospital for an unspecified length of time and received an unknown type of treatment. On an unknown date, the patient eventually died from an unknown cause. It was unknown if an autopsy was performed. At the time of this report, the causality assessment between the unidentified Merck hpv vaccine administered (name and lot number not provided) and the events, were not reported. The reporter considered the event of fever to be life threatening. | ||||||||||||||||||||
Link To This Search Result:
https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=16&SYMPTOMS[]=Death_%2810011906%29&VAX[]=HPV4
Copyright ©
2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166